4 CAR T-cell researchers

One of the most exciting areas in medicine is the emerging field of CAR-T cell therapy, a potentially revolutionary treatment in cancer and a range of other serious diseases. As a world-class centre of medical research, Australia is at the forefront of this area. Here are four ASX-listed companies involved in this fascinating area.

James Dunn

August 11, 2025

10 min read

This article is for Switzer Report subscribers

Already a subscriber? Log in to access this article.

Join thousands of subscribers who rely on Australia's most trusted independent investment research.

Expert Stock Picks Weekly buy, hold and sell recommendations from analysts with decades of experience.

Model Portfolios Professionally curated portfolios updated regularly so you always know what to own.

Ask the Experts Submit your investing questions and get answers from Peter Switzer and the team.

Start Your 21-Day Free Trial

No commitment. Cancel anytime. Plans from $35/month.

“Switzer Report has been invaluable for my investment decisions. The expert analysis and stock picks have consistently helped me build wealth with confidence.”

★★★★★ — Michael J., subscriber since 2019

21-day free trial

Cancel anytime, no lock-in

Secure payment via Stripe